Reduced insulin effect in subclinical fatty liver;Verminderte insulinwirkung bei subklinischer leberzellverfettung

Deutsche Medizinische Wochenschrift

Volumn 129, Issue 16, 2004, Pages 872-875

  Thamer, C ^a   Machann, J ^b   Haap, M ^a   Bachmann, O ^a   Wietek, B ^b   Dahl, D ^a   Tschritter, O ^a   Fritsche, A ^a   Jacob, S ^a   Schick, F ^b   Stumvoll, M ^a,c   Haring H ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; INSULIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY FAT; CORRELATION ANALYSIS; ENZYME BLOOD LEVEL; FAT CONTENT; FATTY LIVER; FEMALE; HEPATOMEGALY; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIVER DISEASE; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; FATTY LIVER; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; LIPIDS; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 11144357016     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-823032     Document Type: Article

References (13)

1. Comert B, Mas MR, Erdem H et al. Insulin resistance in non-alcoholic steatohepatitis. Dig Liver Dis 2001; 33: 353-358
2. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100
3. Garg A, Misra A. Hepatic steatosis, insulin resistance, and adipose tissue disorders. J Clin Endocrinol Metab 2002; 87: 3019-3022
4. Jacob S, Machann J, Rett K et al. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 1999; 48: 1113-1119
5. Marceau P, Biron S, Hould FS et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84: 1513-1517
6. Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850
7. Ryysy L, Hakkinen AM, Goto T et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000; 49: 749-758
8. Schick F, Forster J, Machann J, Huppert P, Claussen CD. Highly selective water and fat imaging applying multislice sequences without sensitivity to B1 field inhomogeneities. Magn Reson Med 1997; 38: 269-274
9. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87: 3023-3028
10. Thamer C, Machann J, Bachmann O et al. Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 2003; 88: 1785-1791
11. Thamer C, Stumvoll M, Niess A et al. Reduced skeletal muscle oxygen uptake and reduced beta-cell function: two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetes. Diabetes Care 2003; 26: 2126-2132
12. Tiikkainen M, Bergholm R, Vehkavaara S et al. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 2003; 52: 701-707
13. Virkamaki A, Korsheninnikova E, Seppala-Lindroos A et al. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 2001; 50: 2337-2343